申请人:Abbott Laboratories
公开号:US06562827B1
公开(公告)日:2003-05-13
Heterocyclically substituted amides of the general formula I
wherein the variables as defined in the specification are useful in pharmaceuticals for the treatment of diseases in which increased interleuken-1 levels occur.
通式I中的杂环取代酰胺,在规范中定义的变量对于治疗发生白细胞介素-1水平升高的疾病的药物是有用的。